Last reviewed · How we verify

NCT06780228: CALMO

Evaluation of a Chatbot With CALMO (Chatbot-Assisted Learning Model) to Enhance Clinical Learning in Nursing Students

Not yet recruiting NA Last updated 17 January 2025
What this trial tests

NA trial testing chatbot-assisted clinical learning in Clinical Competence in 174 participants. Not yet recruiting.

Timeline
11 January 2025
Primary endpoint
30 September 2026
30 December 2026

Quick facts

Lead sponsorCaritas Institute of Higher Education
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment174
Start date11 January 2025
Primary completion30 September 2026
Estimated completion30 December 2026

Drugs / interventions tested

Conditions studied

Sponsor

Caritas Institute of Higher Education

Who can join

18 and older, any sex, with Clinical Competence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present proposed study will design and develop a chatbot to support graduating nursing students' clinical learning. The efficacy of this chatbot technology will be evaluated, using a mixed methods quasi-experimental design. the proposed study hypothesizes that the chatbot-assisted clinical education has the potential to promote clinical performance by improving nursing knowledge, general self-efficacy, and self-reflection and insight.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Clinical Competence

Currently open trials in the same condition.

Other Caritas Institute of Higher Education trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06780228.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing